CHINTYA NUR AFIFAH, - (2024) ANALISIS EFEKTIVITAS BIAYA TERAPI PADA PASIEN HIPERTENSI DENGAN PENYAKIT PENYERTA GAGAL GINJAL KRONIK RAWAT INAP DI RSU PINDAD KOTA BANDUNG. Skripsi thesis, Sekolah Tinggi Farmasi Indonesia.
![[img]](http://repository.stfi.ac.id/style/images/fileicons/text.png) |
Text
S_PSSF_A201008_Title.pdf Download (424kB) |
|
Text
S_PSSF_A201008_Chapter1.pdf Restricted to Repository staff only Download (141kB) |
|
Text
S_PSSF_A201008_Chapter2.pdf Restricted to Repository staff only Download (173kB) |
|
Text
S_PSSF_A201008_Chapter3.pdf Restricted to Repository staff only Download (50kB) |
|
Text
S_PSSF_A201008_Chapter4.pdf Restricted to Repository staff only Download (394kB) |
|
Text
S_PSSF_A201008_Chapter5.pdf Restricted to Repository staff only Download (7kB) |
|
Text
S_PSSF_A201008_Appendix.pdf Restricted to Repository staff only Download (495kB) |
Abstract
Hipertensi merupakan penyakit kronis dengan terapi pengobatan yang membutuhkan biaya yang besar. Penelitian ini bertujuan untuk menganalisis efektivitas biaya terapi pada pasien hipertensi dengan penyakit penyerta gagal ginjal kronik cost-effectiveness di RSU Pindad periode Januari-Desember 2023. Penelitian ini menggunakan metode deskriptif non analitik. Pengambilan data dilakukan secara retrospektif dengan mengakses data rekam medis. Sampel yang memenuhi kriteria inklusi pada penelitian ini adalah sebanyak 40 orang. Analisis efektivitas biaya dilakukan dengan menghitung Average Cost Effectiveness Rasio (ACER) dan Incremental Cost Effectiveness Rasio (ICER) selanjutnya dilakukan analisis sensitivitas untuk mengetahui parameter yang mempengaruhi efektivitas biaya dengan meningkatkan biaya obat menjadi 10%. Hasil penelitian analisis efektivitas biaya terapi pada pasien hipertensi dengan penyakit penyerta gagal ginjal kronik di Rumah Sakit Umum Pindad periode Januari-Desember 2023 didapatkan hasil perhitungan ICER menunjukkan kelompok terapi antihipertensi (Calcium Channel Blocker + Angiotensin Receptor Blocker) dengan nilai ICER terendah yaitu sebesar Rp-7.868,3 menjadi pilihan kedua pada pasien hipertensi dengan penyakit penyerta gagal ginjal kronik. ---- Hypertension is a chronic disease with treatment therapy that requires large costs. This study aims to analyze the cost-effectiveness therapy in hypertensive patients with comorbidities of chronic renal failure cost-effectiveness at Pindad General Hospital for the period January-December 2023. This study used a descriptive nonanalytic method. Data collection was done retrospectively by accessing medical record data. The sample that met the inclusion criteria in this study was 40 people. Cost-effectiveness analysis was carried out by calculating the Average Cost Effectiveness Ratio (ACER) and Incremental Cost Effectiveness Ratio (ICER), then sensitivity analysis was carried out to determine the parameters that affect cost effectiveness by increasing drug costs to 10%. The results of the cost-effectiveness analysis therapy in hypertensive patients with comorbidities of chronic renal failure at Pindad General Hospital for the period January-December 2023 showed that the ICER calculation showed that the antihypertensive therapy group (Calcium Channel Blocker + Angiotensin Receptor Blocker) with the lowest ICER value of Rp. 7,868.3 was the second choice for hypertensive patients with comorbidities of chronic renal failure.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Uncontrolled Keywords: | Hipertensi, Analisis Efektivitas Biaya, Gagal Ginjal. ---- Hypertension, Cost Effectiveness Analysis, Renal Failure |
| Subjects: | R Medicine > RA Public aspects of medicine R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine |
| Divisions: | Program Studi S1 Farmasi |
| Depositing User: | pustakawan - - |
| Date Deposited: | 26 Aug 2024 06:06 |
| Last Modified: | 26 Aug 2024 06:06 |
| URI: | http://repository.stfi.ac.id/id/eprint/1058 |
Actions (login required)
 |
View Item |
